青蒿素耐药性的现状与趋势

Analysis on the Recent Progress and Development Future of Artemisinin Resistance Containment

青蒿素是从我国中草药中通过化学提炼开发出的有价值药物成分,在治疗疟疾方面目前已取得世界瞩目的成绩。但是,世界卫生组织(WHO)一直非常关注因使用青蒿素类药物产生的疟原虫耐药性问题,并专门制定《全球青蒿素耐药性限制计划》等,以避免青蒿素耐药范围的扩大。本文拟从青蒿素的耐药性历史由来入手,分析其发展现状,以期展望该领域的发展趋势。

Artemisinin,a new and a very potent antimalarial drug,is produced by the Chinese medicinal herb artemisia annual. However,World Health Organization（ WHO） has already pay attention to the antimalarial drug efficacy and drug resistance,The Global plan for artemisinin resistance containment（ GPARC） is a call to stop its spread to new areas. This paper is overviewed recent progress on artemisinin resistance containment,and its development future is also prospected.